In a separate metabolic phenotyping cohort, diet-induced-obese C57BL/6J wild-type mice treated with the danegaptide and mirabegron combination therapy daily for 9 days showed a trend towards serum glucose reduction.
← all excerpts
Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention.
1
—
—